Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients

  1. Romero-Ventosa, E.Y.
  2. Blanco-Prieto, S.
  3. González-Piñeiro, A.L.
  4. Rodríguez-Berrocal, F.J.
  5. Piñeiro-Corrales, G.
  6. Páez de la Cadena, M.
Journal:
SpringerPlus

ISSN: 2193-1801

Year of publication: 2015

Volume: 4

Issue: 1

Type: Article

DOI: 10.1186/S40064-015-0891-0 GOOGLE SCHOLAR lock_openOpen access editor